Yahoo! Finance: RIGL News

Rigel gets milestone payment from Daiichi Sankyo (AP)

Wed, 23 Dec 2009 15:56:30 Etc/GMT

Rigel Pharmaceuticals Inc. said Wednesday it received a milestone payment from Daiichi Sankyo, its partner in researching potential cancer treatments.

Rigel Receives Milestone Payment from Daiichi Sankyo for Cancer Ligase Target (PR Newswire)

Wed, 23 Dec 2009 12:30:00 Etc/GMT

Rigel Pharmaceuticals, Inc. today announced that it has received a milestone payment from Daiichi Sankyo Co., Ltd. as part of their collaboration to research and develop cancer treatments aimed at selectively inhibiting ligases, which are intrinsic to cancer cell growth and proliferation.

Rigel Pharma Gives Up Gains (at Barrons.com)

Mon, 21 Dec 2009 21:49:00 Etc/GMT

UPDATE - Incyte sells autoimmune therapies to Lilly (at Reuters)

Mon, 21 Dec 2009 17:21:54 Etc/GMT

Generic Drugs Continue To Accelerate Market Share Expansion According To Sanford Bernstein (Wall Street Transcript)

Mon, 7 Dec 2009 13:18:00 Etc/GMT

67 WALL STREET, New York - December 7, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Eleven Rigel Product Candidate Presentations at 2009 ASH Meeting (PR Newswire)

Tue, 1 Dec 2009 12:30:00 Etc/GMT

Rigel Pharmaceuticals, Inc. today announced that eleven presentations on preclinical studies of the company's product candidates will be given at the upcoming American Society of Hematology Meeting and Exposition in New Orleans, Louisiana from December 5-8, 2009.

Rigel shares rise on RBC analyst upgrade (AP)

Mon, 23 Nov 2009 17:53:31 Etc/GMT

Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.

Rigel Pharms upgraded by RBC Capital Mkts (Briefing.com)

Mon, 23 Nov 2009 12:39:55 Etc/GMT

Piper Jaffray Award Winning Analyst Says Health Care Reform Equity Valuation Fears Have Passed: Stock Picks For Q4 2009 (Wall Street Transcript)

Tue, 10 Nov 2009 20:56:00 Etc/GMT

67 WALL STREET, New York - November 10, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Bristol Licenses Arthritis Drug: BioBuzz (at TheStreet.com)

Tue, 10 Nov 2009 14:20:01 Etc/GMT

Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors (Wall Street Transcript)

Fri, 6 Nov 2009 15:33:00 Etc/GMT

RIGEL PHARMACEUTICALS INC Financials (EDGAR Online Financials)

Fri, 6 Nov 2009 14:04:37 Etc/GMT

New Star Analyst Rankings for Rigel Pharmaceuticals, Inc. (StarMine)

Wed, 4 Nov 2009 14:28:57 Etc/GMT

RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (EDGAR Online)

Tue, 3 Nov 2009 16:56:26 Etc/GMT

Rigel reports $26.7M loss in Q3 (at bizjournals.com)

Tue, 3 Nov 2009 15:05:27 Etc/GMT

Rigel 3Q loss narrows on lower costs (AP)

Tue, 3 Nov 2009 12:49:31 Etc/GMT

Rigel Pharmaceuticals Inc. said Tuesday its third-quarter loss narrowed as the development-stage biotechnology company completed two midstage studies in its rheumatoid arthritis program.

Rigel Announces Third Quarter 2009 Financial Results (PR Newswire)

Tue, 3 Nov 2009 12:00:00 Etc/GMT

Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

6 Stocks Attracting Top Investors (at Motley Fool)

Wed, 28 Oct 2009 16:25:28 Etc/GMT

Rigel Announces Presentations at Two Investor Conferences (PR Newswire)

Wed, 28 Oct 2009 11:30:00 Etc/GMT

Galleon's Biotech Stock Holdings: BioBuzz (at TheStreet.com)

Tue, 20 Oct 2009 17:53:16 Etc/GMT